Deep Longevity spins out of Insilico Medicine to fight ageing
Deep Longevity launches out of Insilico Medicine to transform research into longevity
personalised medicine
C-19: symptom reporting app launched by King’s College London
King’s College London has launched a COVID-19 symptom-tracking app in the UK. The aim is to help slow the outbreak by tracking in real time: How fast the virus is spreading geographically High-risk areas in the UK Who is most at risk, by better understanding symptoms linked to underlying health conditions The app is free to […]
Rare Disease Day: UK aims to lead world in genomic healthcare
The UK government has announced a new National Genomic Healthcare Strategy which sets out how the UK can become the global leader in genomic healthcare.
Genomics England chooses QIAGEN for 5 million genomes project
Genomics England has selected QIAGEN to provide bioinformatic support to the NHS Genomic Medicine Service and its national network of Genomic Laboratory Hubs for 5 million genome project.
JPND announces €30 million call for neurodegenerative disease research
JPND, the EU’s neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.
SOPHiA GENETICS raises USD 77 million to build US business
SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.